Roscovitine (a Cdc2, CDK2, and CDK5 inhibitor) protects against liver diseases by inhibiting macrophage inflammatory actions and HSC activation at the onset of liver injury (Liu et al., 2021). This evidence concerns the gene CDK2 and liver disorder.